Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Poppema

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Oncogene|December 19, 2006
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphomaJ Kluiver, A van den Berg, D de Jong, et al.
Diseases of the Colon and Rectum|April 6, 2001
Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancerW A Bleeker, V M Hayes, A Karrenbeld, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|May 1, 1992
Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigenG D MacLean, M B Bowen-Yacyshyn, J Samuel, et al.
European Journal of Immunology|July 1, 1987
B lymphocyte differentiation in the rat: production and characterization of monoclonal antibodies to B lineage-associated antigensF G Kroese, A S Wubbena, D Opstelten, et al.
Cancer|January 1, 1986
Diagnostic application of a monoclonal antibody against small cell lung cancerP E Postmus, T J Hirschler-Schulte, L De Leij, et al.
Neoplasia (New York, N.Y.)|July 23, 2019
Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." <i>Neoplasia</i> 2009, Feb;11(2):167-176J H Gibcus, L P Tan, G Harms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's DiseaseV Diehl, M Sextro, J Franklin, et al.
Cancer Research|December 1, 1985
Characterization of three new variant type cell lines derived from small cell carcinoma of the lungL de Leij, P E Postmus, C H Buys, et al.
Journal of Clinical Pathology|April 29, 2005
High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphomaR Rust, G Harms, T Blokzijl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphomaT Rüdiger, R D Gascoyne, E S Jaffe, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Oncogene|December 19, 2006
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphomaJ Kluiver, A van den Berg, D de Jong, et al.
Diseases of the Colon and Rectum|April 6, 2001
Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancerW A Bleeker, V M Hayes, A Karrenbeld, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|May 1, 1992
Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigenG D MacLean, M B Bowen-Yacyshyn, J Samuel, et al.
European Journal of Immunology|July 1, 1987
B lymphocyte differentiation in the rat: production and characterization of monoclonal antibodies to B lineage-associated antigensF G Kroese, A S Wubbena, D Opstelten, et al.
Cancer|January 1, 1986
Diagnostic application of a monoclonal antibody against small cell lung cancerP E Postmus, T J Hirschler-Schulte, L De Leij, et al.
Neoplasia (New York, N.Y.)|July 23, 2019
Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." <i>Neoplasia</i> 2009, Feb;11(2):167-176J H Gibcus, L P Tan, G Harms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's DiseaseV Diehl, M Sextro, J Franklin, et al.
Cancer Research|December 1, 1985
Characterization of three new variant type cell lines derived from small cell carcinoma of the lungL de Leij, P E Postmus, C H Buys, et al.
Journal of Clinical Pathology|April 29, 2005
High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphomaR Rust, G Harms, T Blokzijl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphomaT Rüdiger, R D Gascoyne, E S Jaffe, et al.
Pageof 18